fda warning letter hims compounded semaglutide 2025 is moving to restrict mass-marketed GLP-1 products that aren't FDA-approved, companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Hims & Hers Health (HIMS)

A study cited in those guidelines found a 20 percent reduction in the risk of heart attack and stroke for people taking a GLP-1, though experts agree that more research is still needed

Los medicamentos para bajar de peso solo se ofrecen con receta y, por lo general, se consideran para adultos con: BMI de 30 o ms, o BMI de 27 o ms combinado con una afeccin relacionada con el peso (como diabetes, presin arterial alta, colesterol alto o apnea del sueo) La mayora de los medicamentos para bajar de peso se deben usar junto con cambios en el estilo de vida, no como una estrategia independiente

The "Triple G" Mechanism: How it Works GLP-1 (Glucagon-like Peptide-1): Primarily reduces hunger and slows digestion

The most common side effects in trials are gastrointestinal: nausea (around 43% at 12 mg), vomiting (21%), and diarrhoea (33%)